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Data from SARS outbreak due to corona virus 1 has 
shown that high viral load during transmission was 
associated with poor clinical outcome (1). Zou et al has 
reported comparable viral load in throat and 
nasopharyngeal swab of symptomatic and 
asymptomatic covid-19 patients suggesting 
noninvasive ventilation (NIV) induced aerosolization 
of secretion from asymptomatic patients will pose 
similar risk of viral transmission to household contact 
of the Covid-19 patients.(2). WHO has listed 
noninvasive ventilation including CPAP therapy as 
highly aerosol generative intervention putting 
healthcare workers and caregiver of patient at risk of 
contracting the disease (3). 
Recent guidelines regarding home based 
ventilatory support has tried to balance the risk 
associated with stopping the support against risk of 
transmission to family members and caretakers (4, 5) 
we need to discuss this issue broadly in context of 
covid19 outbreak. 
 
NIV: Currently the home based NIV is being used by 
those patients who are at risk of developing 
hypercapnic respiratory failure like COPD, morbid 
obese or having anatomical deformity of chest wall etc. 
as they don’t need intensive monitoring or care in 
healthcare setting. Stopping NIV may lead to 
worsening of symptoms like dyspnea, lethargy, 
confusion, or development of life-threatening 
hypercapnia requiring hospital admission thus further 
increasing the chance of getting Covid-19 infection 
and over burdening the limited health infrastructure 
during pandemic. Most of the patients receiving home 
based NIV are bed ridden and it is easy to isolate them. 
Hence, there is a higher risk of transmission from 
caretaker to patient and once patient is infected then 
there is high risk of transmission to family members, 
caregivers and community. Hence if we are continuing 
home based care of positive patients then proper 
precaution like hand hygiene, using non vented mask 
with viral filters, isolating the patient in proper 
ventilated room and using personal protective 
equipment is necessary as well as our responsibility. 
 
CPAP: Home based CPAP therapy is being used 
currently by obstructive sleep apnea (OSA) patients. 
CPAP therapy has improved quality of life as well as 
there is dramatic improvement in clinical condition of 
OSA patients. Stopping CPAP may lead to worsening 
of symptoms in patients with moderate to severe 
disease.  Increased daytime sleepiness and lethargy 
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will affect patient performance in critical jobs. 
However, if CPAP user is infected then in order to 
prevent its transmission to family members, stopping 
CPAP for 2 weeks along with isolation of the patient 
will be sensible decision. 
With limited data, we believe that risk of 
transmission of coronavirus during home based 
ventilatory support is very high and may have 
potentially lethal consequences. Thus for best interest 
of patients, care givers, family members and for 
community, we call for a consensus opinion that we 
should analyze the risk and benefit before giving 
blanket advise to withhold home based NIV and CPAP 
to all the patients that too during whole period of 
pandemic. 
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